Human Hepatitis B Immunoglobulin (hepatitis b immunoglobulin): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Medication indications

Human Hepatitis B Immunoglobulin

Immunoprophylaxis of hepatitis B

- In case of accidental exposure e.g. skin pricks, contamination of abrasions, spillage into eye or mouth, bites or scratches, in non-immunised subjects (including persons whose vaccination is incomplete or status unknown).

- In haemodialysed patients, until vaccination has become effective.

- In the newborn of a hepatitis B virus carrier-mother (if birthweight ≤1,500g irrespective of e-antigen status of mother; if >1,500g irrespective of mother's HBeAg status but not necessary if she is known to be anti-HBe positive).

- In subjects who did not show an immune response (<10 IU/L of hepatitis B antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis B.

- Sexual contacts of patients with acute hepatitis B within one week of last contact.

- Sexual contacts of newly diagnosed chronic hepatitis B if unprotected contact within the last week.


Molecule: hepatitis b, immunoglobulin

Patients' opinions on Human Hepatitis B Immunoglobulin

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.